Press releases
Your source for Evernorth news.
Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year
Estimated to save individual Accredo patients around $4,000 per year
Biosimilar price will be more than 80% lower than Stelara list price
Accredo patients benefit from the specialty pharmacy’s best-in-class clinical support
Close search filters
Changing filters will change the listed Success Criteria and Techniques
Search results (50)
Press Release
Enhancing Specialty Pharmacy Care Services for TRICARE Beneficiaries
November 20, 2023
Press Release
Express Scripts Introduces New Option to Give Clients Maximum Simplicity in Drug Pricing
November 14, 2023
Express Scripts ClearNetwork offers employers and health plans a new option for simple, “cost-plus” pharmacy pricing for brand, generic, and specialty medications.
Press Release
Programs to lower patient out-of-pocket costs work – but only if manufacturers remain at the table
November 09, 2023
Press Release
Evernorth Acquires Bright.md Technology Platform, Enhances MDLIVE’s Virtual Care Experience for Patients and Clinicians
October 10, 2023
Press Release
Evernorth Introduces Innovative Behavioral Health Measurement-Based Care Program
October 06, 2023
Reinforcing Commitment to Health and Value While Improving Provider Experience
Press Release
MDLIVE Intergenerational Study Shows Mental Health of American Families At-Risk
August 09, 2023